[go: up one dir, main page]

MX2017012759A - Moléculas pequeñas que contienen boro como agentes antiprotozoarios. - Google Patents

Moléculas pequeñas que contienen boro como agentes antiprotozoarios.

Info

Publication number
MX2017012759A
MX2017012759A MX2017012759A MX2017012759A MX2017012759A MX 2017012759 A MX2017012759 A MX 2017012759A MX 2017012759 A MX2017012759 A MX 2017012759A MX 2017012759 A MX2017012759 A MX 2017012759A MX 2017012759 A MX2017012759 A MX 2017012759A
Authority
MX
Mexico
Prior art keywords
boron
small molecules
containing small
antiprotozoal agents
compounds
Prior art date
Application number
MX2017012759A
Other languages
English (en)
Inventor
J Plattner Jacob
Zhang Yong-Kang
T Jacobs Robert
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of MX2017012759A publication Critical patent/MX2017012759A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona, entre otros, compuestos novedosos útiles para tratar infecciones por protozoos, composiciones farmacéuticas que contienen tales compuestos, así como combinaciones de estos compuestos con al menos un agente terapéuticamente eficaz adicional. Fórmula (I) y (II).
MX2017012759A 2015-04-09 2016-04-08 Moléculas pequeñas que contienen boro como agentes antiprotozoarios. MX2017012759A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562145422P 2015-04-09 2015-04-09
US201562152605P 2015-04-24 2015-04-24
PCT/US2016/026772 WO2016164814A1 (en) 2015-04-09 2016-04-08 Boron-containing small molecules as antiprotozoal agents

Publications (1)

Publication Number Publication Date
MX2017012759A true MX2017012759A (es) 2018-05-15

Family

ID=55806821

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012759A MX2017012759A (es) 2015-04-09 2016-04-08 Moléculas pequeñas que contienen boro como agentes antiprotozoarios.

Country Status (14)

Country Link
US (2) US10011616B2 (es)
EP (1) EP3280717A1 (es)
JP (1) JP2018514519A (es)
KR (1) KR20170136570A (es)
CN (1) CN107567456A (es)
AU (1) AU2016246802A1 (es)
BR (1) BR112017021380A2 (es)
CA (1) CA2979891A1 (es)
HK (1) HK1245277A1 (es)
IL (1) IL254770A0 (es)
MX (1) MX2017012759A (es)
RU (1) RU2017134285A (es)
SG (1) SG11201707713UA (es)
WO (1) WO2016164814A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
WO2024094235A1 (en) 2022-11-03 2024-05-10 Univerzita Karlova Use of benzoxaborole-based compounds in therapy of diseases caused by amoebas of the naegleria genus
TR2023001878A1 (tr) * 2023-02-20 2024-08-21 Yedi̇tepe Üni̇versi̇tesi̇ Borun nöronal kaynakli lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1853251T3 (pl) 2005-02-16 2013-09-30 Anacor Pharmaceuticals Inc Halogenopodstawione boronoftalidy do leczenia infekcji
CN106008583A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
KR20130031233A (ko) 2009-07-28 2013-03-28 아나코르 파마슈티칼스 인코포레이티드 삼치환된 붕소 함유 분자

Also Published As

Publication number Publication date
SG11201707713UA (en) 2017-10-30
US20180072760A1 (en) 2018-03-15
KR20170136570A (ko) 2017-12-11
CA2979891A1 (en) 2016-10-13
US10011616B2 (en) 2018-07-03
EP3280717A1 (en) 2018-02-14
JP2018514519A (ja) 2018-06-07
BR112017021380A2 (pt) 2018-07-03
CN107567456A (zh) 2018-01-09
IL254770A0 (en) 2017-12-31
HK1245277A1 (zh) 2018-08-24
AU2016246802A1 (en) 2017-10-05
WO2016164814A1 (en) 2016-10-13
US20180273553A1 (en) 2018-09-27
RU2017134285A (ru) 2019-04-03

Similar Documents

Publication Publication Date Title
MX2012002031A (es) Moleculas pequeñas que contienen boro como agentes antiprotozoarios.
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
EA201990495A1 (ru) Биарильные соединения, применимые в качестве иммуномодуляторов
PH12018502535B1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
BR112018067538A2 (pt) inibidores de ire1-alfa de pequenas moléculas
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
MX347688B (es) Moleculas pequeñas que contienen boro.
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
MY189454A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
PH12018502497A1 (en) Adenosine derivatives for use in the treatment of cancer
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
MY197626A (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
PH12017501879A1 (en) Methods for treating cancer
MX2017012759A (es) Moléculas pequeñas que contienen boro como agentes antiprotozoarios.
PH12021551058A1 (en) Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof
NZ735398A (en) Novel n-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors
MA39337B1 (fr) Modulateurs de pyrazines de gpr6
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
MX2024003785A (es) Inhibidor de inmunosupresion asociado al cancer.
MX2019009362A (es) Compuestos heterociclicos novedosos y sus usos en la prevencion o el tratamiento de infecciones bacterianas.
PH12020500339A1 (en) Novel compounds